Show simple item record

AuthorRigane, Emna
AuthorZughaier, Susu M
Available date2023-01-15T06:01:34Z
Publication Date2022
Publication NameBacterial Sexually Transmitted Infections - New Findings, Diagnosis, Treatment, and Prevention
Identifierhttp://dx.doi.org/10.5772/intechopen.107993
CitationRigane, E., & Zughaier, S. (2022). <em>Neisseria gonorrhoeae</em> Ketol-Acid Reductoisomerase Is a Potential Therapeutic Target. In (Ed.), Bacterial Sexually Transmitted Infections - New Findings, Diagnosis, Treatment, and Prevention [Working Title]. IntechOpen. https://doi.org/10.5772/intechopen.107993
ISBN978-1-80356-750-1
URIhttp://hdl.handle.net/10576/38324
AbstractThe host-adapted human pathogen Neisseria gonorrhoeae is the causative agent of sexually transmitted infection gonorrhea. The increased emergence of gonorrhea infections worldwide, associated with the surging resistance to antimicrobial treatments is alarming. Antimicrobial resistance (AMR) is a global threat to human health and occur through various molecular mechanisms. This research aims to identify molecular therapeutic targets in N. gonorhoeae as a potential antibiotic adjuvant. This work is focused on ketol acid reductor-isomerase enzyme (KARI), an enzyme involved in the branched-chain amino acids biosynthesis. A BLASTp analysis revealed that KARI enzyme is highly conserved in N. gonorrhoeae strains and present in important bacterial pathogens including ESKAPE. Sequence alignment of different KARI proteins from various human bacterial pathogens and gut microbiota demonstrate that residues forming the active site and cofactors binding sites are conserved among all tested KARIs. A 3D homology-based model for gonococcal KARI was generated using Swiss model server and the KARI template from S. aureus. The generated 3D KARI model shows that this enzyme adapts a different conformation upon binding of cofactors, allowing the substrate binding and catalysis, while the active site adapts a closed state.
Languageen
PublisherIntechOpen
SubjectN. Gonorhoeae
KARI- enzyme
therapeutic target
ESKAPE pathogens
antimicrobial resistance
TitleNeisseria gonorrhoeae Ketol-Acid Reductoisomerase Is a Potential Therapeutic Target
TypeBook chapter
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record